ALIMP Implanet S.A.
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.A. was founded in 2006 and is headquartered in Martillac, France.…
Industry Peers
Medical DevicesKey Statistics
About Implanet (EPA: ALIMP)
›
Implanet (EPA: ALIMP) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 49 employees.
The shares were at 0.1378 EUR on 20 November 2026, down 35.3% over 52 weeks. Its 52-week range is 0.1280 EUR to 0.2860 EUR: the price is 51.8% below the high and 7.7% above the low.
Its market capitalisation is 19.82M EUR.
Implanet reports an operating margin of -28.6% and revenue up 22.8% year over year.
Its debt exceeds its cash by 4.45M EUR, a debt-to-equity ratio of 14.66. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.